Trial reportInternational ophthalmology2025
Challenging the routine: evaluating the need for postoperative management in blepharoplasty: a randomized controlled trial.
Trial report in International ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Nerve Block Advance in Blepharoplasty: A Call for Rigorous Validation.Aesthetic plastic surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate the clinical and aesthetic efficacy of postoperative topical treatments compared to conservative management following standard upper eyelid blepharoplasty.
methodsThis prospective, randomized controlled trial included 69 patients undergoing isolated upper eyelid blepharoplasty. Participants were randomized into three groups: (1) antibiotic-steroid ointment (Maxitrol), (2) antibiotic-only ointment (chloramphenicol), and (3) no topical treatment (control). Primary outcomes included patient satisfaction, pain, perceived swelling, and aesthetic results using the Stony Brook Scar Evaluation Scale (SBSES), assessed at one week and four months postoperatively. Adverse events and complications were also recorded.
resultsThere were no statistically significant differences among the three groups in patient-reported outcomes at either time point, including pain (p = 0.05), satisfaction (p = 0.3), or eyelid swelling (p = 0.9). Aesthetic evaluation by a blinded independent senior plastic surgeon showed no significant difference in SBSES scores between groups (p = 0.7). No adverse effects or postoperative infections were reported.
conclusionRoutine use of postoperative topical antibiotic or corticosteroid-containing ointments following standard upper eyelid blepharoplasty does not confer additional benefit in terms of patient satisfaction, symptom control, or aesthetic outcomes when compared with conservative care alone. Given the low infection risk, potential side effects, and concerns regarding antimicrobial resistance, a simplified postoperative regimen focusing on lubrication alone may be sufficient for uncomplicated cases. These findings support a more minimalist approach to postoperative management and emphasize the need for larger, multicenter trials to validate these results across broader surgical contexts.
Indexed as
Identifiers
41400848What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.